ATE510821T1 - Sulfonylpyrrole als histondeacetylaseinhibitoren - Google Patents
Sulfonylpyrrole als histondeacetylaseinhibitorenInfo
- Publication number
- ATE510821T1 ATE510821T1 AT06724113T AT06724113T ATE510821T1 AT E510821 T1 ATE510821 T1 AT E510821T1 AT 06724113 T AT06724113 T AT 06724113T AT 06724113 T AT06724113 T AT 06724113T AT E510821 T1 ATE510821 T1 AT E510821T1
- Authority
- AT
- Austria
- Prior art keywords
- sulfonylpyrroles
- histone deacetylase
- deacetylase inhibitors
- inhibitors
- histone
- Prior art date
Links
- 229940121372 histone deacetylase inhibitor Drugs 0.000 title 1
- 239000003276 histone deacetylase inhibitor Substances 0.000 title 1
- 102000003964 Histone deacetylase Human genes 0.000 abstract 1
- 108090000353 Histone deacetylase Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/48—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05102750 | 2005-04-07 | ||
| PCT/EP2006/003171 WO2006105979A1 (en) | 2005-04-07 | 2006-04-07 | Sulfonylpyrroles as histone deacetylase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE510821T1 true ATE510821T1 (de) | 2011-06-15 |
Family
ID=34939180
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06724113T ATE510821T1 (de) | 2005-04-07 | 2006-04-07 | Sulfonylpyrrole als histondeacetylaseinhibitoren |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20090117074A1 (de) |
| EP (1) | EP1868994B1 (de) |
| JP (1) | JP5054671B2 (de) |
| AT (1) | ATE510821T1 (de) |
| AU (1) | AU2006232773B2 (de) |
| CA (1) | CA2603398A1 (de) |
| WO (1) | WO2006105979A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7842820B2 (en) * | 2004-03-11 | 2010-11-30 | 4Sc Ag | Sulfonylpyrroles |
| DE602006007558D1 (de) | 2005-03-15 | 2009-08-13 | 4Sc Ag | N-sulfonylpyrrole und ihre verwendung als histondeacetylaseinhibitoren |
| EA018698B1 (ru) * | 2005-09-21 | 2013-10-30 | 4Сц Аг | Сульфонилпирролгидрохлориды как ингибиторы гистондезацетилазы |
| KR101256846B1 (ko) | 2005-09-21 | 2013-04-24 | 4에스체 악티엔게젤샤프트 | Ｈｄａｃ의 억제제로서의 신규한 설포닐피롤 |
| EP2100882A1 (de) * | 2008-03-12 | 2009-09-16 | 4Sc Ag | (E) -N -(2-Aminophenyl) -3-{1-[4-(1-methyl-1H-pyrazol-4-yl)- benzolsulfonyl]-1H-pyrrol-3-yl} Acrylamid-Salze |
| AU2009289649B2 (en) | 2008-09-03 | 2016-05-05 | Biomarin Pharmaceutical Inc. | Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors |
| WO2012087234A1 (en) | 2010-12-22 | 2012-06-28 | Idogen Ab | A composition comprising at least to compounds which induces indolamine 2,3-dioxygenase (ido), for the treatment of an autoimmune disorder or suffering from immune rejection of organs |
| US8957066B2 (en) | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| US10059723B2 (en) | 2011-02-28 | 2018-08-28 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| WO2012118782A1 (en) * | 2011-02-28 | 2012-09-07 | Repligen Corporation | Histone deacetylase inhibitors |
| EP2508510A1 (de) | 2011-04-06 | 2012-10-10 | Ikerchem, S.L. | Hydroxyphenylpyrrolverbindungen mit einer Hydroxaminsäure als HDAC-Inhibitoren und medizinische Anwendungen davon |
| RU2665554C2 (ru) | 2013-03-15 | 2018-08-31 | Байомарин Фармасьютикал Инк. | Ингибиторы hdac |
| TW202012395A (zh) * | 2018-04-14 | 2020-04-01 | 德商４Ｓｃ製藥公司 | 用於治療癌症的包含組蛋白去乙醯酶（hdac）抑制劑和tlr7 激動劑和/或tlr8 激動劑的藥物組合產品 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960787A (en) * | 1989-02-06 | 1990-10-02 | Ciba-Geigy Corporation | Certain pyrrolyl-substituted hydroxamic acid derivatives |
| DE69221290T2 (de) * | 1991-12-10 | 1998-01-15 | Shionogi & Co | Auf aromatischen sulfonamiden basierende hydroxamsäurederivate |
| CA2223154A1 (en) * | 1995-06-02 | 1996-12-05 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| KR20100035666A (ko) * | 1999-11-23 | 2010-04-05 | 메틸진 인크. | 히스톤 디아세틸라제의 억제제 |
| US6521618B2 (en) * | 2000-03-28 | 2003-02-18 | Wyeth | 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| US7868204B2 (en) * | 2001-09-14 | 2011-01-11 | Methylgene Inc. | Inhibitors of histone deacetylase |
| US7842820B2 (en) * | 2004-03-11 | 2010-11-30 | 4Sc Ag | Sulfonylpyrroles |
| US7345043B2 (en) * | 2004-04-01 | 2008-03-18 | Miikana Therapeutics | Inhibitors of histone deacetylase |
| DE602006007558D1 (de) * | 2005-03-15 | 2009-08-13 | 4Sc Ag | N-sulfonylpyrrole und ihre verwendung als histondeacetylaseinhibitoren |
-
2006
- 2006-04-07 WO PCT/EP2006/003171 patent/WO2006105979A1/en not_active Ceased
- 2006-04-07 AT AT06724113T patent/ATE510821T1/de not_active IP Right Cessation
- 2006-04-07 US US11/887,268 patent/US20090117074A1/en not_active Abandoned
- 2006-04-07 EP EP06724113A patent/EP1868994B1/de not_active Expired - Lifetime
- 2006-04-07 JP JP2008504694A patent/JP5054671B2/ja not_active Expired - Fee Related
- 2006-04-07 AU AU2006232773A patent/AU2006232773B2/en not_active Ceased
- 2006-04-07 CA CA002603398A patent/CA2603398A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2006232773A1 (en) | 2006-10-12 |
| JP5054671B2 (ja) | 2012-10-24 |
| CA2603398A1 (en) | 2006-10-12 |
| WO2006105979A1 (en) | 2006-10-12 |
| AU2006232773B2 (en) | 2012-04-12 |
| EP1868994B1 (de) | 2011-05-25 |
| EP1868994A1 (de) | 2007-12-26 |
| US20090117074A1 (en) | 2009-05-07 |
| JP2008534637A (ja) | 2008-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201001359A1 (ru) | Гетероциклические соединения в качестве ингибиторов cxcr2 | |
| ATE552255T1 (de) | 4-aminoindazole | |
| DK1861365T3 (da) | N-sulfonylpyrroler og anvendelse deraf som histondeacetylaseinhibitorer | |
| CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
| EA201100037A1 (ru) | Органические соединения | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| MA32508B1 (fr) | Composes organiques | |
| EA200800865A1 (ru) | Биарилзамещенные гетероциклические ингибиторы lta4h для лечения воспаления | |
| EA201200323A1 (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
| EA201070278A1 (ru) | Ингибиторы гамма-секретазы | |
| EA200800321A1 (ru) | Ингибиторы гистондеацетилазы | |
| EA200901124A1 (ru) | Соединения формулы (i) в качестве ингибиторов серинпротеазы | |
| EA201300684A1 (ru) | Производные 6-амино-2-фениламино-1н-бензимидазол-5-карбоксамида и их применение в качестве ингибиторов микросомной простагландин-е2-синтазы-1 | |
| EP2049505A4 (de) | Isoform-selektive hdac-hemmer | |
| PA8713501A1 (es) | INHIBIDORES DE 11-BETA HIDROXIESTEROIDE DEHIDROGENASA - 11ßHSD1 | |
| EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
| TW200640924A (en) | VEGF-R2 inhibitors and methods | |
| EA201270590A1 (ru) | Ингибиторы акт | |
| LTC1912640I2 (lt) | HDAC inhibitoriaus panobinostato panaudojimas mielomos gydymui | |
| EP1991226A4 (de) | Histondeacetylase-hemmer | |
| NZ596783A (en) | Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds | |
| EA200801362A1 (ru) | Пиримидинил бензотиофеновые соединения | |
| DK1761520T3 (da) | Kinaseinhibitorer | |
| EP2010168A4 (de) | Histondeacetylase-inhibitoren | |
| EA201070039A1 (ru) | Спироциклы в качестве ингибиторов 11-бета гидроксилстероиддегидрогеназы типа 1 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |